mRNA-1345

· Moderna, Inc.

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for mRNA-1345, covering 2024-08-07 to 2026-08-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults [Phase 3]

See pricing